Samsung Biologics pays GSK $280M to secure first US manufacturing site
Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making…
Samsung Biologics buys GSK’s Human Genome Sciences for $280M
Secures the company’s first U.S.-based manufacturing site, strengthening and diversifying its global supply networkAdditional investments planned to expand…
Samsung Biologics Pays $280M For U.S. Drug Manufacturing Facility- Biotech
Marking a significant expansion of the company’s global footprint and long-term commitment to the U.S. market, Samsung Biologics…